Lai Tzu-Jung, Roxburgh Campbell, Boyd Kathleen Anne, Bouttell Janet
Health Economics and Health Technology Assessment, School of Health and Wellbeing, University of Glasgow College of Medical Veterinary and Life Sciences, Glasgow, UK
School of Cancer Sciences, University of Glasgow College of Medical Veterinary and Life Sciences, Glasgow, UK.
BMJ Open. 2024 Sep 16;14(9):e076750. doi: 10.1136/bmjopen-2023-076750.
To undertake a review of systematic reviews on the clinical outcomes of robotic-assisted surgery across a mix of intracavity procedures, using evidence mapping to inform the decision makers on the best utilisation of robotic-assisted surgery.
We included systematic reviews with randomised controlled trials and non-randomised controlled trials describing any clinical outcomes.
Ovid Medline, Embase and Cochrane Library from 2017 to 2023.
We first presented the number of systematic reviews distributed in different specialties. We then mapped the body of evidence across selected procedures and synthesised major findings of clinical outcomes. We used a measurement tool to assess systematic reviews to evaluate the quality of systematic reviews. The overlap of primary studies was managed by the corrected covered area method.
Our search identified 165 systematic reviews published addressing clinical evidence of robotic-assisted surgery. We found that for all outcomes except operative time, the evidence was largely positive or neutral for robotic-assisted surgery versus both open and laparoscopic alternatives. Evidence was more positive versus open. The evidence for the operative time was mostly negative. We found that most systematic reviews were of low quality due to a failure to deal with the inherent bias in observational evidence.
Robotic surgery has a strong clinical effectiveness evidence base to support the expanded use of robotic-assisted surgery in six common intracavity procedures, which may provide an opportunity to increase the proportion of minimally invasive surgeries. Given the high incremental cost of robotic-assisted surgery and longer operative time, future economic studies are required to determine the optimal use of robotic-assisted surgery capacity.
对一系列腔内手术中机器人辅助手术临床结局的系统评价进行综述,采用证据图谱法为决策者提供有关机器人辅助手术最佳应用的信息。
我们纳入了包含随机对照试验和非随机对照试验且描述了任何临床结局的系统评价。
2017年至2023年的Ovid Medline、Embase和Cochrane图书馆。
我们首先展示了分布在不同专业的系统评价数量。然后我们梳理了所选手术的证据主体,并综合了临床结局的主要发现。我们使用一种测量工具来评估系统评价,以评价系统评价的质量。通过校正覆盖面积法处理原始研究的重叠问题。
我们的检索确定了165篇发表的关于机器人辅助手术临床证据的系统评价。我们发现,除手术时间外,对于所有结局,与开放手术和腹腔镜手术相比,机器人辅助手术的证据大多是积极的或中性的。与开放手术相比,证据更为积极。手术时间的证据大多是消极的。我们发现,由于未能处理观察性证据中固有的偏倚,大多数系统评价质量较低。
机器人手术有强有力的临床有效性证据基础,以支持在六种常见腔内手术中扩大机器人辅助手术的应用,这可能为增加微创手术的比例提供机会。鉴于机器人辅助手术的增量成本高且手术时间长,未来需要进行经济学研究以确定机器人辅助手术能力的最佳使用方式。